Trademarkia Logo

About 110 Trademarks found for “TABLET DESIGN”

Filters

Also try searching for:

TABLET DESIGN*

TABL*

*IGN

TA*GN

878656
WITHDRAWN BY OWNER

on 25 Feb 2002

CARDURA TABLET DESIGN

PFIZER CANADA INC.

878656 · 20 May 1998

005

Pharmaceutical preparation, namely, an anti-hypertensive preparation c...

819695
WITHDRAWN BY OWNER

on 21 Jun 2005

PINK TABLET DESIGN

PFIZER CANADA INC.

819695 · 2 Aug 1996

005

Pharmaceutical preparations and substances containing ranitidine or ra...

815151
WITHDRAWN BY OWNER

on 17 Nov 2003

BROWN TABLET DESIGN

ASTRAZENECA AB

815151 · 12 Jun 1996

005

Pharmaceutical tablets containing omeprazole magnesium for use in the ...

815155
WITHDRAWN BY OWNER

on 17 Nov 2003

PINK TABLET DESIGN

ASTRAZENECA AB

815155 · 12 Jun 1996

005

Pharmaceutical tablets containing omeprazole magnesium for use in the ...

795807
WITHDRAWN BY OWNER

on 10 Apr 2002

BEIGE TABLET DESIGN

MERCK FROSST CANADA & CO./ MERCK FROSST CANADA & CIE.

795807 · 25 Oct 1995

005

Pharmaceutical preparations, namely, famotidine.

768551
ABANDONED - SECTION 38(7)

on 16 Mar 1999

REACTINE TABLET DESIGN

PFIZER CANADA INC.

768551 · 16 Nov 1994

005

Pharmaceutical preparation, namely, an anti-allergy preparation contai...

768550
REFUSED IN ACCORDANCE WITH TRADEMARKS OPPOSITION BOARD DECISION

on 11 Jun 2002

NORVASC TABLET DESIGN

PFIZER CANADA INC.

768550 · 16 Nov 1994

005

Pharmaceutical preparation, namely, an antianginal/antihypertensive pr...

768548
WITHDRAWN BY OWNER

on 12 Jun 2002

DIFLUCAN TABLET DESIGN

PFIZER CANADA INC.

768548 · 16 Nov 1994

005

Pharmaceutical preparation, namely, an anti-fungal preparation contain...

737383
WITHDRAWN BY OWNER

on 22 Mar 2002

TABLET-YELLOW DESIGN

NOVARTIS PHARMA CANADA INC.

737383 · 21 Sept 1993

005

Pharmaceutical tablets containing clozapine for the treatment of schiz...

723086
WITHDRAWN BY OWNER

on 11 Apr 2002

TABLET DESIGN (BEIGE)

MERCK FROSST CANADA & CO./ MERCK FROSST CANADA & CIE.

723086 · 18 Feb 1993

005

Pharmaceutical preparations, namely, famotidine.

Owners

Reckitt benckiser n.V. (21)

Astrazeneca ab (11)

Pfizer canada inc. (10)

Bristol-myers squibb company (6)

Pfizer products inc. a connecticut corporation (5)

Purdue pharma (5)

Ciba-geigy canada ltd. (4)

Merck frosst canada & co./ merck frosst canada & cie. (4)

Glaxo group limited (3)

Henkel kgaa (3)

Categories

Class 5 (81)

Class 3 (30)

Class 1 (21)

Class 11 (19)

Class 21 (17)

Class 16 (6)

Class 9 (3)

Class 30 (3)

Class 25 (2)

Class 35 (2)

Class 38 (2)

Class 42 (2)

Class 2 (1)

Class 4 (1)

Class 6 (1)

Class 7 (1)

Class 8 (1)

Class 10 (1)

Class 12 (1)

Class 13 (1)

Class 14 (1)

Class 15 (1)

Class 17 (1)

Class 18 (1)

Class 19 (1)

Class 20 (1)

Class 22 (1)

Class 23 (1)

Class 24 (1)

Class 26 (1)

Class 27 (1)

Class 28 (1)

Class 29 (1)

Class 31 (1)

Class 32 (1)

Class 33 (1)

Class 34 (1)

Class 36 (1)

Class 37 (1)

Class 39 (1)

Class 40 (1)

Class 41 (1)

Class 43 (1)

Class 44 (1)

Class 45 (1)

Correspondents

Smart & biggar lp (36)

Gowling wlg (canada) llp (29)

Marks & clerk (9)

Borden ladner gervais llp (3)

Osler, hoskin & harcourt llp (3)

Cassels brock & blackwell llp (1)

Perley-robertson, hill & mcdougall llp (1)

Page 3 of 11